Rapid DNA Status at IntegenX
(Room :Room 18-19)
20 Sep 16
9:15 AM
-
9:30 AM
Presenter: Robert Schueren, CEO, IntegenX Inc.
Profile: Bob has nearly 30 years of commercial and operational experience, and holding leadership positions in life science and diagnostic companies for more than two decades. Most recently, he was Vice President and General Manager, Genomics for Agilent Technologies. Prior to joining Agilent in 2010, he was the Global Head of Clinical Biomarkers and Operations, and Deputy Global Head of Molecular Medicine Labs for Genentech, Inc., a company he joined in 2006. While at Genentech, Bob held increasingly responsible positions including Senior Director, Development Sciences and Director Companion Diagnostics. Prior to Genentech, he was the Executive Vice President and Chief Operating Officer of Arcturus Bioscience from 2003 to 2006. From 1997 to 2002, Bob held senior leadership positions with Accumetrics and previously held commercial positions with Biosite Diagnostics, Gen-Probe and Abbott Diagnostics. Bob holds a BS in Pharmacy from Temple University, and serves as a member of the board of directors for IntegenX.
Presentation Abstract: IntegenX Rapid DNA technology does for DNA testing what digital fingerprint scanners did for fingerprints. Rather than waiting weeks to know if a suspect or arrestee can be linked to any unsolved crimes, agencies equipped with Rapid DNA can generate DNA profiles within hours. In this presentation, IntegenX will discuss the status of their Rapid DNA technology, current performance, and user applications.